These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 14583472

  • 1. Constitutive activation of Stat5b contributes to carcinogenesis in vivo.
    Xi S, Zhang Q, Gooding WE, Smithgall TE, Grandis JR.
    Cancer Res; 2003 Oct 15; 63(20):6763-71. PubMed ID: 14583472
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
    Nagy ZS, Wang Y, Erwin-Cohen RA, Aradi J, Monia B, Wang LH, Stepkowski SM, Rui H, Kirken RA.
    J Leukoc Biol; 2002 Oct 15; 72(4):819-28. PubMed ID: 12377952
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition.
    Lee TK, Man K, Poon RT, Lo CM, Yuen AP, Ng IO, Ng KT, Leonard W, Fan ST.
    Cancer Res; 2006 Oct 15; 66(20):9948-56. PubMed ID: 17047057
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Signal transducers and activators of transcription 5B potentiates v-Src-mediated transformation of NIH-3T3 cells.
    Kazansky AV, Rosen JM.
    Cell Growth Differ; 2001 Jan 15; 12(1):1-7. PubMed ID: 11205741
    [Abstract] [Full Text] [Related]

  • 10. Activation of signal transducer and activator of transcription 5 is required for progression of autochthonous prostate cancer: evidence from the transgenic adenocarcinoma of the mouse prostate system.
    Kazansky AV, Spencer DM, Greenberg NM.
    Cancer Res; 2003 Dec 15; 63(24):8757-62. PubMed ID: 14695191
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Epidermal growth factor receptor--mediated stat3 signaling blocks apoptosis in head and neck cancer.
    Rubin Grandis J, Zeng Q, Drenning SD.
    Laryngoscope; 2000 May 15; 110(5 Pt 1):868-74. PubMed ID: 10807365
    [Abstract] [Full Text] [Related]

  • 13. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
    Shipley JM, Waxman DJ.
    Toxicol Appl Pharmacol; 2004 Sep 15; 199(3):275-84. PubMed ID: 15364543
    [Abstract] [Full Text] [Related]

  • 14. Dysregulated expression of COOH-terminally truncated Stat5 and loss of IL2-inducible Stat5-dependent gene expression in Sezary Syndrome.
    Mitchell TJ, Whittaker SJ, John S.
    Cancer Res; 2003 Dec 15; 63(24):9048-54. PubMed ID: 14695224
    [Abstract] [Full Text] [Related]

  • 15. Constitutively active STAT5A and STAT5B in vitro and in vivo: mutation of STAT5 is not a frequent cause of leukemogenesis.
    Yamada K, Ariyoshi K, Onishi M, Miyajima A, Hayakawa F, Towatari M, Saito H, Oka Y, Asano S, Nosaka T, Kitamura T.
    Int J Hematol; 2000 Jan 15; 71(1):46-54. PubMed ID: 10729993
    [Abstract] [Full Text] [Related]

  • 16. STAT signaling in head and neck cancer.
    Song JI, Grandis JR.
    Oncogene; 2000 May 15; 19(21):2489-95. PubMed ID: 10851047
    [Abstract] [Full Text] [Related]

  • 17. VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma.
    Chen H, Ye D, Xie X, Chen B, Lu W.
    Gynecol Oncol; 2004 Sep 15; 94(3):630-5. PubMed ID: 15350351
    [Abstract] [Full Text] [Related]

  • 18. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
    Báez A, Cantor A, Fonseca S, Marcos-Martinez M, Mathews LA, Muro-Cacho CA, Muñoz-Antonia T.
    Clin Cancer Res; 2005 May 01; 11(9):3191-7. PubMed ID: 15867212
    [Abstract] [Full Text] [Related]

  • 19. Signal transducer and activator of transcription-5 activation and breast cancer prognosis.
    Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, Sauter G, Rui H.
    J Clin Oncol; 2004 Jun 01; 22(11):2053-60. PubMed ID: 15169792
    [Abstract] [Full Text] [Related]

  • 20. Effect of erythropoietin on Leydig cell is associated with the activation of Stat5 pathway.
    Yamazaki T, Kanzaki M, Kamidono S, Fujisawa M.
    Mol Cell Endocrinol; 2004 Jan 15; 213(2):193-8. PubMed ID: 15062567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.